Medicine and Dentistry
Cystic Fibrosis
100%
Clinical Trial
69%
Patient
30%
Patient-Reported Outcome
26%
Measurement
23%
Sputum
17%
Epithelial Cell
15%
Child
14%
Computer Assisted Tomography
13%
Ensure
12%
Silo-Filler's Disease
12%
Development
12%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Comprehension
11%
Diseases
9%
Pediatrics
9%
Low Drug Dose
9%
Lung
9%
Bronchiectasis
9%
Adult
9%
Cells
8%
Polyp
8%
Ussing Chamber
8%
Biological Marker
7%
Therapeutic Procedure
7%
Quality of Life
7%
Cystic Fibrosis Transmembrane Conductance Regulator
7%
Caregiver
7%
Inflammation
7%
Patient with Cystic Fibrosis
6%
Lung Infection
6%
Lung Volume
6%
Combination Therapy
6%
Age
6%
Chest
5%
Magnetic Resonance Imaging
5%
Assessment
5%
Inpatient
5%
Toddlers
5%
Clinician
5%
Drug
5%
Chemotherapeutic Agent
5%
Nursing and Health Professions
Cystic Fibrosis
20%
Bronchiectasis
17%
Cystic Fibrosis
13%
Patient
12%
Patient-Reported Outcome
10%
Actigraph
9%
Pedometer
8%
Sodium Chloride
8%
Accelerometer
7%
Time
7%
Validity
6%
Evaluation Study
6%
Monitoring
5%
Diseases
5%
Transtheoretical Model
5%
Quality of Life
5%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
32%
Cystic Fibrosis
29%
Cystic Fibrosis
24%
Cystic Fibrosis Transmembrane Conductance Regulator
13%
Chloride
8%
Diseases
8%
Biological Marker
7%
SARS Coronavirus
6%
Lung Disease
5%